SleepUCI: Effect of Asynchronies on Sleep Disruption During Mechanical Ventilation

Sponsor
Althaia Xarxa Assistencial Universitària de Manresa (Other)
Overall Status
Completed
CT.gov ID
NCT05847374
Collaborator
(none)
50
1
42
1.2

Study Details

Study Description

Brief Summary

Mechanically ventilated (MV) patients in the Intensive Care Unit (ICU) are highly susceptible to sleep disruption. Several studies in the last 15 years have demonstrated an extremely poor sleep quality and abnormal sleep pattern evaluated by polysomnography (PSG) devices (the gold standard method for evaluating sleep quality and quantity).

Patient-ventilator interaction is frequently poor leading to asynchronies of varied type and consequences. Moderate-to-severe asynchronies are associated with longer mechanical ventilation, weaning failure and mortality.

The goal of this study is to look for an association between poor sleep quality and patient-ventilator asynchronies.

This study is an observational, physiological study investigating sleep quality and quantity in MV patients by recording portable PSG (from 22:00 to 08:00) at night while continuously monitoring 24h/day of patient-ventilator interaction (BetterCare system).

Condition or Disease Intervention/Treatment Phase
  • Device: Polysomnography

Detailed Description

This clinical physiological study took place after MV patients have survived the initial critical admission phase (severe hypoxemia or shock) and before approaching weaning.

After enrolment, a single night, sleep architecture was recorded using standard PSG (electroencephalography, right and left electrooculography, submental electromyography and electrocardiography) from 24:00 to 8:00. Pulse oximetry (SpO2) and heart rate will be recorded continuously during the PSG.

Assessment of delirium was performed using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) every 8 hours (at 08:00, 16:00 and 24:00) from day 0 until discharge.

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Relationship Between Asynchronies and Sleep Disruption in Mechanically Ventilated Patients: a Prospective Cohort Study
Actual Study Start Date :
Jan 1, 2019
Actual Primary Completion Date :
Jul 1, 2022
Actual Study Completion Date :
Jul 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Correlation between sleep architecture using Odds Ratio Product (ORP) and asynchronies. [24 hours]

    ORP ranges and Sleep Architecture. Type and amount of asynchronies.

Secondary Outcome Measures

  1. Comparison of sleep disturbances between diurnal and nocturnal asynchronies [24 hours]

    ORP ranges and Sleep Architecture. Type and amount of asynchronies.

  2. Correlation between asynchronies and delirium [28 days]

    Type and amount of asynchronies and CAM-ICU delirium.

  3. Correlation between sleep disruption and delirium [28 dyas]

    ORP ranges and Sleep Architecture and CAM-ICU delirium.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years

  • Intubated and mechanically ventilated

Exclusion Criteria:
  • Presence of recent major central nervous system disease impairing consciousness with Glasgow Coma Scale ≤ 8 with intubation

  • Patients with a sleep breathing disorder when it is predominantly central sleep apnea; patients with predominantly obstructive sleep apnea can be included.

  • Severe hemodynamic instability (high dose of vasopressors).

  • Receiving muscle paralysis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Althaia Xarxa Assistencial Manresa Barcelona Spain 08243

Sponsors and Collaborators

  • Althaia Xarxa Assistencial Universitària de Manresa

Investigators

  • Study Director: Rafael Fernandez Fernandez, PhD, Althaia Xarxa Assitencial de Manresa

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Carles Subirà Cuyàs, Principal Investigator, Althaia Xarxa Assistencial Universitària de Manresa
ClinicalTrials.gov Identifier:
NCT05847374
Other Study ID Numbers:
  • CE 18-74
First Posted:
May 6, 2023
Last Update Posted:
May 10, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Carles Subirà Cuyàs, Principal Investigator, Althaia Xarxa Assistencial Universitària de Manresa

Study Results

No Results Posted as of May 10, 2023